Latest revenue
$0
as of 2025-09-30
Latest net income
—
as of 2025-09-30
Net margin
—
as of 2025-09-30
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $50.5M
- Enterprise value
- $50.5M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $10.00
- 52-wk low
- $0.20
- Beta
- —
- Shares out
- 99.0M
5-year trend
What this company does
DESCRIPTION OF BUSINESS DESCRIPTION OF BUSINESS Our Corporate History and Background Goldenwell Biotech, Inc. was incorporated on August 20, 2019. Our fiscal year end is December 31, and we have no subsidiaries. Our business offices are currently located at 581 Boston Mills Road, Suite 300, Hudson, Ohio 44236. We do not conduction operations and only receive mail at such location. Summary Financial Information The tables and information below are derived from our financial statements as of December 31, 2024. December 31, 2024 Financial Summary Cash and Cash Equivalents $49,404 Total Assets 224,192 Total Liabilities 271,433 Total Stockholders’ Equity $(47,241) Exclusive Patent License…
AI summary unavailable — showing raw filing excerpt
Generated from GWLL's filing dated 2025-05-15
Key risks
ITEM 1A. RISK FACTORS As a “smaller reporting company,” as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information called for by this Item.
AI summary unavailable — showing raw filing excerpt
Generated from GWLL's filing dated 2025-05-15
Profitability
Gross margin
46.0%
2.8%Operating margin
-88559.7%
1672.8%Net margin
-94602.9%
1786.2%Return on equity
278.4%
300.9%Return on assets
-58.7%
14.0%Leverage
Debt / equity
-5.75×
439.6%Debt / assets
121.1%
92.6%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q3 2025 2025-09-30 | $0 | — | — | — | — |
Q2 2025 2025-06-30 | $0 | -100.0% | $-5.2K | +89.5% | — |
Q1 2025 2025-03-31 | $0 | — | $-34.4K | -11.0% | — |
Q4 2024 2024-12-31 | $0 | — | $-27.5K | — | — |
Q3 2024 2024-09-30 | $0 | -100.0% | $-23.1K | +34.9% | — |
Q2 2024 2024-06-30 | $139 | -49.6% | $-49.9K | -84.3% | -35913.7% |
Q1 2024 2024-03-31 | $0 | — | $-31.0K | — | — |
Q3 2023 2023-09-30 | $382 | — | $-35.4K | — | -9268.6% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Food and Kindred Products · SIC 2000
Your notes
Keep private notes on GWLL — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
No insider transactions on file for GWLL in the last 12 months.
Source: SEC Form 4 filings. Backfill runs nightly.
Who owns GWLL
No institutional holdings on file for GWLL yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once GWLL's latest filing finishes processing.